BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22871818)

  • 1. A simple diagnostic strategy for RhD typing in discrepant cases in the Indian population.
    Kulkarni S; Kasiviswanathan V; Ghosh K
    Blood Transfus; 2013 Jan; 11(1):37-42. PubMed ID: 22871818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterisation of RhD variants in North Indian blood donor population.
    Khetan D; Verma A; Chaudhary RK; Shukla JS
    Transfus Med; 2020 Aug; 30(4):295-303. PubMed ID: 32488899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serologic and molecular characterization of D variants in Brazilians: impact for typing and transfusion strategy.
    Credidio DC; Pellegrino J; Castilho L
    Immunohematology; 2011; 27(1):6-11. PubMed ID: 22356480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-D reagents should be chosen accordingly to the prevalence of D variants in the obstetric population.
    Lukacevic Krstic J; Dajak S; Bingulac-Popovic J; Dogic V; Mratinovic-Mikulandra J
    J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28649781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype analysis to clarify RhD variants in discrepant samples of Chilean population.
    Aburto A; Zapata D; Retamales E; Fernández J; Barra G; Peña F; Cárcamo S; Saavedra N; Sandoval C; Orellana J; Caamaño J
    Front Immunol; 2023; 14():1299639. PubMed ID: 38116010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serologic profiling of D variants in donor routine: unveiling the impact on false-negative results and alloimmunization.
    Arnoni CP; Vendrame TA; Silva FS; Silva NM; Cortez A; Latini F; Castilho L
    Immunohematology; 2024 Jun; 40(2):47-53. PubMed ID: 38910444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varied distribution of RhD epitopes in the Indian population.
    Kulkarni SS; Gupte SC; Vasantha K; Mohanty D; Ghosh K
    Natl Med J India; 2007; 20(4):169-71. PubMed ID: 18085120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RHD variants in Flanders, Belgium.
    Van Sandt VS; Gassner C; Emonds MP; Legler TJ; Mahieu S; Körmöczi GF
    Transfusion; 2015 Jun; 55(6 Pt 2):1411-7. PubMed ID: 25413499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variant RHD Types in Brazilians With Discrepancies in RhD Typing.
    Campos FC; Mota MA; Aravechia MG; Torres KB; Bub CB; Kutner JM; Castilho L
    J Clin Lab Anal; 2016 Nov; 30(6):845-848. PubMed ID: 27076392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular RH blood group typing of serologically D-/CE+ donors: the use of a polymerase chain reaction-sequence-specific primer test kit with pooled samples.
    Londero D; Fiorino M; Miotti V; de Angelis V
    Immunohematology; 2011; 27(1):25-8. PubMed ID: 22356483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to identify candidates for D variant genotyping.
    Luo X; Keller MA; James I; Grant M; Liu S; Massey KS; Czulewicz A; Nance S; Li Y
    Blood Transfus; 2018 May; 16(3):293-301. PubMed ID: 28488958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of
    Hudgins JP; Matsushita C; Tuma CW; O'Brien L; Shulman IA
    Immunohematology; 2021; 37(4):165-170. PubMed ID: 34964318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining serology and molecular typing of weak D role in improving D typing strategy in Egypt.
    Abdelrazik AM; Elshafie SM; Ezzat Ahmed GM; Abdelaziz HM
    Transfusion; 2013 Nov; 53(11 Suppl 2):2940-4. PubMed ID: 23362929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of commercial anti-D reagents in the identification of partial D variants in Indian population.
    Kulkarni SS; Vasantha K; Gupte SC; Mohanty D; Ghosh K
    Indian J Med Res; 2007 May; 125(5):641-4. PubMed ID: 17642499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serologic findings of RhD alleles in Egyptians and their clinical implications.
    Hussein E; Teruya J
    Transfus Apher Sci; 2014 Oct; 51(2):184-7. PubMed ID: 25219636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the serological underrecognition of patients with weak or partial RHD variants.
    Ramsey G; Barriteau CM
    Transfusion; 2024 May; 64(5):920-928. PubMed ID: 38634174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of DEL phenotype in RhD negative donor population of north India.
    Samir S; Jain A; Marwaha N
    Transfus Apher Sci; 2015 Aug; 53(1):34-7. PubMed ID: 25818997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of RhD variant phenotypes among blood donors: A study from the coastal region of India.
    Polavarapu I; Mishra G; Shastry S; Kulkarni S
    Transfus Apher Sci; 2021 Aug; 60(4):103142. PubMed ID: 33962886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RHD alleles among pregnant women with serologic discrepant weak D phenotypes from a multiethnic population and risk of alloimmunization.
    Bub CB; Aravechia MG; Costa TH; Kutner JM; Castilho L
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28374955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of weak D in blood donors typed as D positive by the Olympus PK 7200.
    Jenkins CM; Johnson ST; Bellissimo DB; Gottschall JL
    Immunohematology; 2005; 21(4):152-4. PubMed ID: 16472016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.